MOH CLINICAL PRACTICE GUIDELINES 2/2016
1MOH CLINICAL PRACTICE GUIDELINES 2/2016LIPIDSEXECUTIVE SUMMARYChapter of Family Medicine PhysiciansAcademy of Medicine, SingaporeCollege of Family Physicians, SingaporeSingapore Cardiac SocietyChapter of EndocrinologistsChapter of General PhysiciansCollege of Physicians, SingaporeEndocrine & Metabolic Society of SingaporeContents PageIntroduction and how to use this document 2Lipids in coronary artery disease 4Classification & screening for dyslipidemia 4Risk assessment of CAD in dyslipidemia 6Target lipid levels 8Lifestyle changes 10Drug therapy 12Special considerations 16Quality indicators for lipid management 19Levels of evidence and grades of recommendation 262 EXECUTIVE SUMMARY OF RECOMMENDATIONS IntroductionThis is the executive summary of the MOH CLINICAL PRACTICE GUIDELINES (CPG) on Lipids.
• HDL High density lipoprotein • HMG-CoA 3-hydroxy-3-methyl-glutaryl-CoA • IDL Intermediate density lipoprotein • LDL Low density lipoprotein • Lp(a) Lipoprotein(a) ... The steps taken for risk stratification are illustrated in Figure 1. First, very high risk and high risk patients can be identified based on whether they have existing ...
Download MOH CLINICAL PRACTICE GUIDELINES 2/2016
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: